1. 3074 Platinum-pemetrexed palliative chemotherapy in malignant pleural mesothelioma from Spanish BEMME database The Spanish Lung Cancer Group (SLCG). (September 2015) Authors: Remon, J.; Reguart, N.; Garcia, Y.; Nadal, E.; Lopez-castro, R.; Garcia-campelo, R.; Martin-martorell, P.; Juan, O.; Olmedo, E.; Trancho, F.; Domine, M.; Ponce, S.; Cumplido, D.; Majem, M.; Massuti, B.; Porta, R.; Rodriguez-abreu, D.; Provencio, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune checkpoint inhibitors in non-small cell lung cancer (NSCLC): Approaches on special subgroups and unresolved burning questions. (March 2018) Authors: Remon, J.; Vilariño, N.; Reguart, N. Journal: Cancer treatment reviews Issue: Volume 64(2018) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?. (December 2018) Authors: Remon, J.; Hendriks, L.E.; Cabrera, C.; Reguart, N.; Besse, B. Journal: Cancer treatment reviews Issue: Volume 71(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Malignant pleural mesothelioma: New hope in the horizon with novel therapeutic strategies. Issue 1 (January 2015) Authors: Remon, J.; Reguart, N.; Corral, J.; Lianes, P. Journal: Cancer treatment reviews Issue: Volume 41:Issue 1(2015) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group. (September 2020) Authors: Remon, J.; Nadal, E.; Dómine, M.; Ruffinelli, J.; García, Y.; Pardo, J.C.; López, R.; Cilleruelo, A.; García-Campelo, R.; Martín, P.; Juan, O.; González-Larriba, J.L.; Provencio, M.; Olmedo, E.; Ponce, S.; Cumplido, D.; Barenys, C.; Majem, M.; Massutti, B.; Rodriguez-Abreu, D. Journal: Lung cancer Issue: Volume 147(2020) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC. (February 2022) Authors: Rodríguez-Abreu, D.; Cobo, M.; García-Román, S.; Viteri-Ramírez, S.; Jordana-Ariza, N.; García-Peláez, B.; Reguart, N.; Aguilar, A.; Codony-Servat, J.; Drozdowskyj, A.; Molina-Vila, M.A.; d'Hondt, E.; Rosell, R. Journal: Lung cancer Issue: Volume 164(2022) Page Start: 8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗